You just read:

Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail

News provided by

Reportlinker

Jan 14, 2013, 06:50 EST